EP1268723B1 - Pearly luster concentrates - Google Patents

Pearly luster concentrates Download PDF

Info

Publication number
EP1268723B1
EP1268723B1 EP01929292A EP01929292A EP1268723B1 EP 1268723 B1 EP1268723 B1 EP 1268723B1 EP 01929292 A EP01929292 A EP 01929292A EP 01929292 A EP01929292 A EP 01929292A EP 1268723 B1 EP1268723 B1 EP 1268723B1
Authority
EP
European Patent Office
Prior art keywords
oder
bis
anionic
surfactant
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP01929292A
Other languages
German (de)
French (fr)
Other versions
EP1268723A1 (en
Inventor
Gerd H. Dahms
Klaus Kwetkat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sasol Germany GmbH
Original Assignee
Sasol Germany GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sasol Germany GmbH filed Critical Sasol Germany GmbH
Publication of EP1268723A1 publication Critical patent/EP1268723A1/en
Application granted granted Critical
Publication of EP1268723B1 publication Critical patent/EP1268723B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/0005Other compounding ingredients characterised by their effect
    • C11D3/0089Pearlescent compositions; Opacifying agents
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/66Non-ionic compounds
    • C11D1/83Mixtures of non-ionic with anionic compounds
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D17/00Detergent materials or soaps characterised by their shape or physical properties
    • C11D17/0008Detergent materials or soaps characterised by their shape or physical properties aqueous liquid non soap compositions
    • C11D17/0026Structured liquid compositions, e.g. liquid crystalline phases or network containing non-Newtonian phase
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/20Organic compounds containing oxygen
    • C11D3/2093Esters; Carbonates
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/02Anionic compounds
    • C11D1/04Carboxylic acids or salts thereof
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/02Anionic compounds
    • C11D1/12Sulfonic acids or sulfuric acid esters; Salts thereof
    • C11D1/29Sulfates of polyoxyalkylene ethers
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/66Non-ionic compounds
    • C11D1/72Ethers of polyoxyalkylene glycols

Definitions

  • the invention relates to aqueous, flowable pearlescent concentrates comprising one or more pearlescing components, gemini surfactants and at least one further surfactant.
  • Cosmetic hair and body cleansers, dishwashing detergents and liquid detergents and cleaners contain substances which give the formulations mentioned a pearlescent appearance in order to improve the visual appearance of wetted surfaces and thus to increase the commercial value.
  • substances for example finely powdered natural substances such as mica, fish-silver, inorganic materials such as bismuth oxychloride and titanium dioxide pigments, metal salts of higher fatty acids, fatty acid monoesters or diesters, fatty acid alkanolamides or long-chain fatty alcohols.
  • the only effect and task of pearlescent concentrate in the effect of giving the end product a pearl or silk gloss and this with a very easy to handle, so low viscosity, very stable and not adversely affecting the properties of the final product Pearly luster.
  • the pearlescent concentrate must not contain skin or mucous membrane irritating components.
  • active ingredients e.g. Vitamins, enzymes and proteins, which are often easy to reduce, oxidize or hydrolyze, are not possible here without special pre-treatment.
  • the present invention relates to surfactant compositions and the use of aqueous, flowable pearlescent concentrates according to claims 1 and 6.
  • the pearlescent concentrate is used in concentrations of particularly preferably 1.0 to 5% by weight in the end product.
  • the pearlescing component in the application formulation not only performs the function of imparting a pearl or silk luster of high optical density and brilliance to the end product, but also reduces the irritation potential of other anionic surfactants, leads to better foaming characteristics, the foam contains much surfactant solution and is very high creamy.
  • the pearlescent concentrate according to the invention leads to a good moisturizing effect of the application formulation and can be used as a vehicle for inclusion and thus protection of active components against oxidation, reduction or hydrolysis and for their controlled release (eg odorous substances only when used as intended).
  • the inventors have been determined, without wishing to be bound by theory, that unlike described in the literature (RL Crombie, SH Nicholson, Cons. Journal Com. Esp. Deterg., 28 (1998) 87-94), in the pearlescent effect compositions of the invention, the pearlescent components are not present in the form of small, oriented in the surfactant bilayers, crystals.
  • the pearlescent concentrate according to the invention forms elongated multilamellar liquid-crystalline layers.
  • the elongated multilamellar liquid-crystalline layers are composed of several surfactant bilayers. When stretched according to the invention, these stretched multilamellar layers also remain in the application formulation or at water concentrations typically found in formulations (1 to 90% by weight).
  • the elongated multilamellar liquid crystalline layers which form in compositions of the invention differ markedly from the concentric membrane vesicles described for encapsulating drugs (see, for example, WO 99/27907).
  • the arrangement of the elongated multilamellar liquid crystalline layers does not correspond to that of vesicles, but rather that of a system of emulsifier and co-emulsifier forming a gel network (J. Britto, Euro Cosmetics, 9 (1998) 27-32).
  • the shape of the elongated multilamellar liquid-crystalline layers is shown in FIG.
  • This is the pearlescent concentrate given in the examples as formulation (A).
  • the pearlescent concentrate was snap-frozen with liquid nitrogen, broken, the fracture surface was covered with conductive material and examined with the Scanning Electron Microscope (ESEM).
  • ESEM Scanning Electron Microscope
  • On display are the elongated multilamellar structures, which can be used for the inclusion of active substances. These differ markedly from the spherical, onion-like structures of conventional compositions, such as e.g. in WO 99/27907 are described.
  • active ingredients which themselves have an at least slightly amphoteric character, i. contain both hydrophobic and polar groups, which are incorporated as part of the bilayers. These active ingredients do not affect the efficiency of the pearlescing agent.
  • Oil-soluble active substances can be taken up by the elongated multilamellar liquid-crystalline layers and thus remain in front of them, e.g. Oxidation, reduction or hydrolysis protected.
  • Water soluble actives can be placed in the hydrous layers between the elongated multilamellar liquid crystalline layers.
  • the protective effect of the pearlescent concentrate can be determined simply by the concentration of the intact active substance over a certain period of time.
  • gemini surfactants are surface-active compounds which consist of at least two, preferably two, surfactant units, ie of hydrophilic head group and hydrophobic group, which are identified by at least one, preferably spacer, spacer Near the head group are linked together.
  • the gemini or gemini silk are also called dimer surfactants and bear their name because of their special design.
  • anionic, nonionic, cationic and amphoteric gemini surfactants there are anionic, nonionic, cationic and amphoteric gemini surfactants.
  • conventional surfactants which are likewise classified into these groups, gemini surfactants can also carry combinations of head groups of different character. These are usually combinations of nonionic and ionic groups.
  • the gemini surfactant has at least one anionic group.
  • gemini surfactants preferably used in the surfactant compositions according to the invention include those which contain nitrogen atoms at the point of attachment between spacer, hydrophilic and hydrophobic group. These include preferably gemini surfactants with spacers containing amines or amides, but also spacers deriving from dicarboxylic acids, hydrophilic double head groups derived from betaine structures which optionally have side groups prepared by alkoxylation (in particular ethoxylation), the sulfonic acid, phosphonic acid, carboxylic acid or alcohol groups (including polyhydric alcohols), and hydrophobic double chains of 5 to 25 carbon atoms, which may be branched or unbranched and may carry up to 2 non-contiguous double bonds.
  • gemini surfactants as represented by the formulas are particularly suitable for the surfactant compositions of the invention.
  • the preferred structural variants are explained in greater detail by the definition of the substituents / spacers, wherein each individual definition of a substituent / spacer can also characterize the gemini surfactant taken by itself.
  • the disclosure of the writings mentioned under AI to D.IV is hereby explicitly made the content of this application with regard to the definition of the gemini surfactants.
  • Variant A structures based on amide- or amine-containing spacers
  • Gemini surfactants of the general formula (A.III) are amphoteric compounds, so that they can also become cationic in a correspondingly acidic surrounding medium.
  • Variant B structures based on amide- or amine-containing spacers
  • Variant C structures based on amide- or amine-containing spacers
  • Mild in the sense of the invention means that the corresponding compounds / compositions are free of labeling (for example according to Directive 67-548-EEC, Hazardous Substances Ordinance) with respect to their irritation potential for skin and eyes.
  • the "poor foaming characteristic” property means that these surfactants, in their capacity as further detergent component, fall short of two of the three values listed below in the evaluation of their foaming behavior.
  • the "poor foaming characteristic” property means that these surfactants, in their capacity as further detergent components, fall short of two of the three values listed below in the evaluation of their foaming behavior.
  • the surfactant solution to be examined is 10 min. stirred at 1500 rev / min with apparatus with blade stirrer according to Figure 2/3 to 4/4, wherein the solution is slightly heated (from room temperature to about 35 ° C). After stirring for 10 minutes, the resulting foam is skimmed off from above and subjected to direct microscopy - in this case the lamella thickness is measured in mm and the number of foam bubbles in the image section is determined.
  • the foaming behavior of a surfactant under flowing cold tap water is also assessed.
  • 2 g of surfactant are distributed on the palm of your hand and rubbed evenly under running water.
  • Surfactants are judged to be good foaming if they have all three criteria with values of ⁇ 20 mm in the lamella thickness, ⁇ 20 bubbles in the image section (both directly after foaming) and a foaming behavior rated 3.
  • FIGS. 2 to 4 The method used for foam production is shown schematically in FIGS. 2 to 4.
  • the following experimental setup was chosen for all investigations in order to evaluate the influence of the surfactant mixtures on the foaming behavior:
  • alcohol ethoxylates having 6 to 13 carbon atoms and 4 to 15 moles of ethylene oxide, e.g. MARLIPAL® O13 / 120, Laureth-9 or MARLIPAL® 1012/6, and other nonionic surfactants with comparable HLB and a molecular weight ⁇ 800 g / mol.
  • the active substances according to the invention are substances which are particularly sensitive to reduction or oxidation, substances which are particularly sparingly soluble in water and oil or substances which are particularly sensitive to hydrolysis or surfactants.
  • Particularly suitable here are antioxidants, vitamins (especially tocopherol, retinol) and their derivatives, especially their esters, enzymes, proteins and pheromones.
  • substances which due to their acidity can cause problems in the formulation, such as ⁇ -hydroxy acids, are also suitable.
  • organic UV absorbers for example for perfuming or insect repellent, such as especially thiols, ternary or cyclic amines, natural essences whose insect repellent effect is known, for example citric or orange terpene, neem oil extract or insect repellent pheromones suitable for inclusion in the pearlescent concentrate.
  • odorous substances for example for perfuming or insect repellent, such as especially thiols, ternary or cyclic amines, natural essences whose insect repellent effect is known, for example citric or orange terpene, neem oil extract or insect repellent pheromones suitable for inclusion in the pearlescent concentrate.
  • odorous substances for example for perfuming or insect repellent, such as especially thiols, ternary or cyclic amines, natural essences whose insect repellent effect is known, for example citric or orange terpene, neem oil extract or insect repellent pheromones suitable for inclusion in
  • the combination gemini surfactant / poor foaming detergent component is dispensed with, it may be necessary in the case of insufficient stability of the active ingredients to add agents for stabilizing the lamellar layers (stabilizers) .
  • agents for stabilizing the lamellar layers are particularly suitable here.
  • Particularly suitable here are cholesterol and its derivatives as well as phytosterols and their derivatives as well as saturated or unsaturated fatty acids, in particular C 12 to C 22 fatty acids.
  • hydrophilic compounds can be used in both cases as a stabilizer, wherein said compounds additionally ensure better flowability of the compositions of the invention: glycerol or ethylene glycol or 1,2-propylene glycol, butylene glycol, hexylene glycol and / or polyethylene glycol having an average molecular weight of 80 bis 1,000 g / mol.
  • the pearlescent concentrates according to the invention can be prepared by mixing the components (A), (B), (C), (D) and (E) at 20 to 80 ° C, preferably at 40 to 50 ° C, and at 30 to 80 ° C, preferably at 40 to 50 ° C water is added.
  • the pearlescent effect sets in at 25 to 30 ° C and is stable at temperatures up to 60 ° C.
  • the finished pearlescent concentrate can be mixed with the application formulation at room temperature.
  • the temperature-dependent viscosity of the concentrates is determined to check the temperature stability of the concentrates.
  • Examples of pearlescent concentrates according to the invention are the following table compositions: [CTFA INCI] formulation A [weight%] B [weight%] PEG-3 stearates 10 10 Laureth-9 18 0 Isotrideceth-13 0 18 Sodium Lauroyl Lactylate, Sodium, Dicocoylethylenediamine PEG-15 sulfate (Geminitensid - Diamide ether sulfate) (CERALUTION® F) 10 10 PEG-400 8th 8th Aqua 54 54 [CTFA INCI] formulation C [weight%] D [% by weight] Glycol stearate 10 10 Laureth-9 18 0 Isotrideceth-13 0 18 Sodium Lauroyl Lactylate, Sodium Dicocoylethylenediamine PEG-15 sulfate (Gemini surfactant - Diamide Ether Sulfate) 10 10 PEG-400 8th 8th Aqua 54 54 [CTFA INCI] formulation E [% by weight] F [weight
  • compositions of the invention to effectively encapsulate active agents can be e.g. can be detected by the pH during storage of the formulation G and in each case the same amount of ascorbyl dipalmitate in water (see diagram 1/1).
  • the significant drop in pH indicates the hydrolysis of the ascorbyl dipalmitate. If this ester is encapsulated as in Formulation G, there is no significant hydrolysis.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Wood Science & Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Detergent Compositions (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Aqueous pearly luster concentrate comprises: (A) an anionic surfactant component comprising an anionic gemini surfactant(s) and a poorly foaming anionic detergent component(s) and/or a electrolyte stable anionic surfactant(s); (B) a nonionic surfactant(s); (C) a pearl luster component(s); and optionally (D) an active agent(s); and/or (E) a stabilizer(s).

Description

Die Erfindung betrifft wäßrige, fließfähige Perlglanzkonzentrate enthaltend ein oder mehrere perlglanzgebende Komponenten, Geminitenside und zumindest ein weiteres Tensid.The invention relates to aqueous, flowable pearlescent concentrates comprising one or more pearlescing components, gemini surfactants and at least one further surfactant.

Kosmetische Haar- und Körperreinigungsmittel, Geschirrspülmittel und flüssige Wasch- und Reinigungsmittel enthalten zur Verbesserung des optischen Erscheinungsbilds benetzter Oberflächen und damit zur Steigerung des Handelswertes, häufig Substanzen, die den genannten Zubereitungen ein perlglanzartiges Aussehen verleihen. Zur Erreichung eines derartigen Effektes können die verschiedensten Substanzen eingesetzt werden, beispielsweise feingepulverte Naturstoffe, wie Glimmer, Fischsilber, anorganische Materialien, wie Wismutoxichlorid und Titandioxidpigmente, Metallsalze höherer Fettsäuren, Fettsäureglykolmono- oder -diester, Fettsäurealkanolamide oder langkettige Fettalkohole.Cosmetic hair and body cleansers, dishwashing detergents and liquid detergents and cleaners contain substances which give the formulations mentioned a pearlescent appearance in order to improve the visual appearance of wetted surfaces and thus to increase the commercial value. To achieve such an effect, a wide variety of substances can be used, for example finely powdered natural substances such as mica, fish-silver, inorganic materials such as bismuth oxychloride and titanium dioxide pigments, metal salts of higher fatty acids, fatty acid monoesters or diesters, fatty acid alkanolamides or long-chain fatty alcohols.

Üblicherweise werden zur Herstellung kommerziell erhältlicher Endverbraucher-Tensidformulierungen fließfähige Perlglanzkonzentrate eingesetzt, die zumeist organische perlglanzgebende Substanzen enthalten. Solche Perlglanzkonzentrate haben den Vorteil, daß sie kalt in Tensidformulierung eingebracht werden können, der Perlglanz also nicht mehr durch Erwärmen der ganzen Zubereitung auf 60 bis 80 °C hergestellt werden muss (R.L. Crombie, S.H. Nicholson, Comun. Journal Com. Esp. Deterg. 28 (1998)87-94). Diese Perlglanzkonzentrate können vom Stand der Technik ausgehend folgendermaßen zusammengesetzt sein:

  1. 1. aus einer perlglanzgebenden organischen Komponente, wie z.B. Fettsäureglykolester oder Fettsäureglycerinester der Stearinsäure
  2. 2. aus Dispergiermitteln, wie z.B. anionischen Tensiden (z.B. Laurylethersulfat oder Fettsäureamidopropylbetaine)
  3. 3. aus Kristallisationshilfsmitteln, die nach dem Stand der Technik den Zweck haben, die perlglanzgebenden Komponenten in der gewünschten Form kristallisieren zu lassen
Usually, commercially available end-use surfactant formulations are prepared using flowable pearlescent concentrates, which mostly contain organic pearlescing substances. Such pearlescent concentrates have the advantage that they can be introduced cold into the surfactant formulation, ie the pearlescence no longer has to be prepared by heating the entire preparation to 60 to 80 ° C. (RL Crombie, SH Nicholson, Comun. Journal Com. Esp. Deterg. 28 (1998) 87-94). These pearlescent concentrates may be composed of the prior art as follows:
  1. 1. from a pearlescing organic component, such as fatty acid glycol esters or fatty acid glycerol esters of stearic acid
  2. 2. from dispersants, such as anionic surfactants (eg, lauryl ether sulfate or fatty acid amidopropylbetaines)
  3. 3. from crystallization aids, which have the purpose in the prior art to crystallize the pearlescing components in the desired form

Unabhängig davon, mit welchen Komponenten der Perlglanzeffekt hergestellt wird, besteht nach bisheriger Auffassung die einzige Wirkung und Aufgabe des Perlglanzkonzentrates in dem Effekt, dem Endprodukt einen Perl- oder auch Seidenglanz zu verleihen, und dies mit einem möglichst einfach zu handhabenden, also niedrigviskosen, sehr stabilen und die Eigenschaften des Endproduktes nicht negativ beeinflussenden Perlglanzkonzentrat. Insbesondere darf das Perlglanzkonzentrat keine Haut oder Schleimhaut irritierenden Komponenten enthalten.Regardless of which components of the pearlescent effect is produced, according to the previous view, the only effect and task of pearlescent concentrate in the effect of giving the end product a pearl or silk gloss, and this with a very easy to handle, so low viscosity, very stable and not adversely affecting the properties of the final product Pearly luster. In particular, the pearlescent concentrate must not contain skin or mucous membrane irritating components.

Für zusätzlich erforderliche Eigenschaften, die in vielen schäumenden reinigenden Zubereitungen im Bereich Personal Care gefordert werden, beispielsweise Herabsetzung des Irritationspotentials des verwendeten anionischen Haupttensides, Schaumverbesserung hinsichtlich Anschäumbarkeit, Gehalt an Waschflotte, Cremigkeit und Rückfettung, müssen weitere Wirkkomponenten eingesetzt werden. Die Verwendung von Aktivstoffen, z.B. Vitamine, Enzyme und Proteine, die oft leicht zu reduzieren, oxidieren oder hydrolysieren sind, ist hier ohne besondere Vorbehandlung nicht möglich.For additionally required properties which are required in many foaming cleansing preparations in the field of personal care, for example reduction of the irritation potential of the anionic main surfactant used, foam improvement with regard to foamability, content of wash liquor, creaminess and refatting, further active components must be used. The use of active ingredients, e.g. Vitamins, enzymes and proteins, which are often easy to reduce, oxidize or hydrolyze, are not possible here without special pre-treatment.

Eine deutliche Vereinfachung der Formulierungen ergäbe sich, wenn viele oder alle der genannten Funktionen von einer der ohnehin verwendeten Komponenten der Tensid - Zusammensetzung erfüllt würde. Darüber hinaus erschlösse sich eine bisher nicht gekannte technische Flexibilität, wenn Aktivstoffe einfach in eine der genannten Zubereitungen eingebaut werden könnten.A clear simplification of the formulations would result if many or all of the functions mentioned were fulfilled by one of the components of the surfactant composition which was in any case used. In addition, a hitherto unknown technical flexibility would be apparent if active substances could simply be incorporated into one of the stated preparations.

Überraschend wurde festgestellt, daß bei der Verwendung von

  • anionischen Geminitensiden enthaltenden Tensidzusammensetzungen zusammen mit einer anionischen Detergenskomponente mit schlecht schäumender Charakteristik und/oder
    elektrolytstabilen anionischen Tensiden,
  • in Kombination mit zumindest einem nichtionischen Tensid und
  • einem Perlglanzgeber,

das Perlglanzkonzentrat zu einem multifunktionellen Baustein wird.Surprisingly, it has been found that when using
  • anionic gemini surfactants containing surfactant compositions together with an anionic detergent component with poor foaming characteristics and / or
    electrolyte-stable anionic surfactants,
  • in combination with at least one nonionic surfactant and
  • a pearlescer,

the pearlescent concentrate becomes a multifunctional building block.

Die vorliegende Erfindung betrifft Tensidzusammensetzungen und die Verwendung wäßriger, fließfähiger Perlglanzkonzentrate gemäß Anspruch 1 und 6.The present invention relates to surfactant compositions and the use of aqueous, flowable pearlescent concentrates according to claims 1 and 6.

Bevorzugte Ausführungsformen der Erfindung sind Gegenstand der Unteransprüche.Preferred embodiments of the invention are subject of the dependent claims.

Vorzugsweise werden die anionischen Geminitenside (A1.1) zusammen mit der anionischen Detergenskomponente mit schlecht schäumender Charakteristik (A1.2) in folgendem Verhältnis in der anionischen Tensidkomponente eingesetzt:

  • (A1.1) zu 10 bis 80 Gew.%, bevorzugt 20 bis 60 Gew.-% oder sogar 30 bis 50 Gew.%, jeweils bezogen auf die Summe der Komponenten (A1.1) und (A1.2), ein oder mehrere anionische Geminitenside und
  • (A1.2) zum verbleibenden Rest, d.h. zu 90 bis 20 Gew.%, bzw. zu 80 bis 40 Gew.% oder zu 70 bis 50 Gew.%, jeweils bezogen auf die Summe der Komponente (A1.1) und (A1.2) ein oder mehrere anionische Detergenskomponenten mit schlecht schäumender Charakteristik.
The anionic gemini surfactants (A1.1) are preferably used together with the anionic detergent component having a poorly foaming characteristic (A1.2) in the following ratio in the anionic surfactant component:
  • (A1.1) to 10 to 80 wt.%, Preferably 20 to 60 wt .-% or even 30 to 50 wt.%, Each based on the sum of the components (A1.1) and (A1.2), a or more anionic gemini surfactants and
  • (A1.2) to the remainder, ie to 90 to 20 wt.%, Or to 80 to 40 wt.% Or to 70 to 50 wt.%, In each case based on the sum of component (A1.1) and ( A1.2) one or more anionic detergent components having poorly foaming characteristics.

Das Perlglanzkonzentrat wird in Konzentrationen von besonders bevorzugt 1.0 bis 5 Gew% im Endprodukt eingesetzt.The pearlescent concentrate is used in concentrations of particularly preferably 1.0 to 5% by weight in the end product.

Die Perlglanzkomponente übernimmt in der Anwendungsformulierung überraschend nicht nur die Funktion, dem Endprodukt einen Perl- oder Seidenglanz hoher optischer Dichte und hervorragender Brillanz zu verleihen, sondern vermindert das Irritationspotential anderer anionischer Tenside, führt zu einer besseren Anschäumcharakteristik, der Schaum enthält viel Tensidlösung und ist sehr cremig. Darüber hinaus führt das erfindungsgemäße Perlglanzkonzentrat zu einer guten rückfettenden Wirkung der Anwendungsformulierung und kann als Vehikel zum Einschluss und damit zum Schutz von Aktivkomponenten gegen Oxidation, Reduktion oder Hydrolyse sowie zu deren kontrollierter Freigabe (z.B. Geruchsstoffe erst bei der bestimmungsgemäßen Verwendung) genutzt werden.Surprisingly, the pearlescing component in the application formulation not only performs the function of imparting a pearl or silk luster of high optical density and brilliance to the end product, but also reduces the irritation potential of other anionic surfactants, leads to better foaming characteristics, the foam contains much surfactant solution and is very high creamy. In addition, the pearlescent concentrate according to the invention leads to a good moisturizing effect of the application formulation and can be used as a vehicle for inclusion and thus protection of active components against oxidation, reduction or hydrolysis and for their controlled release (eg odorous substances only when used as intended).

Folglich können Formulierungen für die kosmetische Haar- und Körperreinigung, Geschirrspülmittel und flüssige Wasch- und Reinigungsmittel durch Nutzung des erfindungsgemäßen multifunktionellen Perlglanzes stark vereinfacht werden, da der Perlglanz nun zusätzlich Funktionen anderer, in diesem Falle überflüssiger Zusätze oder dann nur noch in geringerem Maße notwendiger Zusätze übernimmt, wie z.B. Rückfettungskomponenten, Schaurnverbesserer und Irritationsminderer. Genannt seien hier Cocoamidopropylbetain und Isethionate.Consequently, formulations for cosmetic hair and body cleansing, dishwashing detergents and liquid detergents and cleaners can be greatly simplified by using the multifunctional pearlescence according to the invention, since the pearlescent now additionally functions other, in this case superfluous additives or then only to a lesser extent necessary additives takes over, such as Refatting components, Schaurnverbesserer and Irritationsminderer. Cocoamidopropyl betaine and isethionates may be mentioned here.

Darüber hinaus muss nun nicht mehr die ganze Formulierung für den Einbau eines Aktivstoffes, wie bei strukturierten Flüssigwaschmitteln üblich, angepasst werden, denn der Aktivstoff kann im Perlglanz sicher verkapselt und erst bei der bestimmungsgemäßen Anwendung freigesetzt werden.In addition, it is no longer necessary to adapt the entire formulation for the incorporation of an active substance, as is customary with structured liquid detergents, because the active substance can be safely encapsulated in the pearlescence and released only when it is used as intended.

Verzichtet man auf die Kombination Geminitensid(e) und schlecht anschäumende Komponente (entsprechend der Deutschen Patentanmeldung 199 43 681.9) und setzt statt dessen (weniger bevorzugt) ein elektrolytstabiles anionisches Tensid ein, weist ein solches Perlglanzkonzentrat noch die Eigenschaft auf, die Aktivstoffe zu verkapseln, allerdings ist die Verwendung der Kombination Geminitensid / schlecht schäumende Detergenskomponente bevorzugt, weil diese zu einem besseren Einschluss des Aktivstoffes und zu einer höheren Stabilität der Zusammensetzung führt.If the combination of gemini surfactant (e) and poorly foaming component (according to German Patent Application 199 43 681.9) is dispensed with and an (instead of) an electrolyte-stable anionic surfactant is used instead, such a pearlescent concentrate still has the property of encapsulating the active substances. however, the use of the combination gemini surfactant / poor foaming detergent component is preferred because it results in better incorporation of the active and higher stability of the composition.

Weiterhin haben die Erfinder - ohne an die Theorie gebunden wollen zu sein - festgestellt worden, daß anders als in der Literatur beschrieben (R.L. Crombie, S.H. Nicholson, Comun. Journal Com. Esp. Deterg. 28 (1998) 87-94), in den erfindungsgemäßen Perlglanzeffekt aufweisenden Zusammensetzungen die Perlglanzkomponenten nicht in Form kleiner, in den Tensiddoppelschichten orientierten, Kristallen vorliegen.Furthermore, the inventors have been determined, without wishing to be bound by theory, that unlike described in the literature (RL Crombie, SH Nicholson, Comun. Journal Com. Esp. Deterg., 28 (1998) 87-94), in the pearlescent effect compositions of the invention, the pearlescent components are not present in the form of small, oriented in the surfactant bilayers, crystals.

Das erfindungsgemäße Perlglanzkonzentrat bildet längliche multilamellare flüssigkristalline Schichten. Die länglichen multilamellaren flüssigkristallinen Schichten sind aus mehreren Tensiddoppelschichten aufgebaut. Diese gestreckten multilamellaren Schichten bleiben - bei erfindungsgemäßem Einsatz - auch in der Anwendungsformulierung oder bei Wasserkonzentrationen, wie sie typischerweise in Formulierungen anzutreffen sind (1 bis 90 Gew%) erhalten.The pearlescent concentrate according to the invention forms elongated multilamellar liquid-crystalline layers. The elongated multilamellar liquid-crystalline layers are composed of several surfactant bilayers. When stretched according to the invention, these stretched multilamellar layers also remain in the application formulation or at water concentrations typically found in formulations (1 to 90% by weight).

Die länglichen multilamellaren flüssigkristallinen Schichten, die sich in erfindungsgemäßen Zusammensetzungen ausbilden, unterschieden sich deutlich von den aus konzentrischen Membranen aufgebauten Vesikeln, wie sie zum Verkapseln von Wirkstoffen beschrieben wurden (siehe z.B. WO 99/27907). Die Anordnung der länglichen multilamellaren flüssigkristallinen Schichten entspricht nicht der von Vesikeln, sondern eher der eines Systems aus Emulgator und Co-Emulgator, das ein Gelnetzwerk ausbildet (J. Britto, Euro Cosmetics, 9 (1998) 27-32).The elongated multilamellar liquid crystalline layers which form in compositions of the invention differ markedly from the concentric membrane vesicles described for encapsulating drugs (see, for example, WO 99/27907). The arrangement of the elongated multilamellar liquid crystalline layers does not correspond to that of vesicles, but rather that of a system of emulsifier and co-emulsifier forming a gel network (J. Britto, Euro Cosmetics, 9 (1998) 27-32).

Die Form der länglichen multilamellaren flüssigkristallinen Schichten ist aus Figur 1/4 ersichtlich. Hierbei handelt es sich um das in den Beispielen als Formulierung (A) wiedergegebene Perlglanzkonzentrat. Hierbei wurde das Perlglanzkonzentrat mit flüssigem Stickstoff schockgefroren, gebrochen, die Bruchfläche mit leitfähigem Material belegt und mit dem Rasterelektronenmikroskop (ESEM) untersucht. Zu sehen sind die länglichen multilamellaren Strukturen, die für den Einschluß von Aktivsubstanzen genutzt werden können. Dies unterscheiden sich deutlich von den spärischen, zwiebelartig aufgebauten Strukturen herkömmlicher Zusammensetzungen, wie sie z.B. in der WO 99/27907 beschrieben sind.The shape of the elongated multilamellar liquid-crystalline layers is shown in FIG. This is the pearlescent concentrate given in the examples as formulation (A). Here, the pearlescent concentrate was snap-frozen with liquid nitrogen, broken, the fracture surface was covered with conductive material and examined with the Scanning Electron Microscope (ESEM). On display are the elongated multilamellar structures, which can be used for the inclusion of active substances. These differ markedly from the spherical, onion-like structures of conventional compositions, such as e.g. in WO 99/27907 are described.

Besonders gut für das Verkapseln von Aktivstoffen im Perlglanzsystem eignen sich Aktivstoffe, die selbst einen zumindest leicht amphoteren Charakter haben, d.h. sowohl hydrophobe wie auch polare Gruppen enthalten, wobei diese als Teil der Doppelschichten eingebaut werden. Diese Aktivstoffe beeinträchtigen die Effizienz des Perlglanzgebers nicht. Öllösliche Aktivstoffe können von den länglichen multilamellaren flüssigkristallinen Schichten aufgenommen werden und bleiben damit auch vor z.B. Oxidation, Reduktion oder Hydrolyse geschützt. Wasserlösliche Aktivstoffe können in den wasserhaltigen Schichten zwischen den länglichen multilamellaren flüssigkristallinen Schichten untergebracht werden. Die Schutzwirkung des Perlglanzkonzentrates kann einfach anhand der Konzentration des unversehrten Aktivstoffes über einen bestimmten Zeitraum ermittelt werden.Particularly suitable for the encapsulation of active ingredients in the pearlescent system are active ingredients which themselves have an at least slightly amphoteric character, i. contain both hydrophobic and polar groups, which are incorporated as part of the bilayers. These active ingredients do not affect the efficiency of the pearlescing agent. Oil-soluble active substances can be taken up by the elongated multilamellar liquid-crystalline layers and thus remain in front of them, e.g. Oxidation, reduction or hydrolysis protected. Water soluble actives can be placed in the hydrous layers between the elongated multilamellar liquid crystalline layers. The protective effect of the pearlescent concentrate can be determined simply by the concentration of the intact active substance over a certain period of time.

Unter Geminitensiden versteht man - im Rahmen der vorliegenden Erfindung - grenzflächenaktive Verbindungen, die aus mindestens zwei, vorzugsweise aus zwei, Tensideinheiten, d.h. aus hydrophiler Kopfgruppe und hydrophober Gruppe, bestehen, die durch mindestens einen, vorzugsweise durch einen Abstandhalter, Spacer genannt, in der Nähe der Kopfgruppe miteinander verknüpft sind. Die Gemini- oder Zwillingstenside werden auch Dimertenside genannt und tragen ihren Namen aufgrund ihrer besonderen Bauart. Abhängig von der Natur der Kopfgruppe gibt es anionische, nichtionische, kationische und amphotere Geminitenside. Anders als konventionelle Tenside, die man ebenfalls in diese Gruppen einteilt, können Geminitenside jedoch auch Kombinationen von Kopfgruppen unterschiedlichen Charakters tragen. Dabei handelt es sich meist um Kombinationen aus nichtionischen und ionischen Gruppen. Vorzugsweise weist das Geminitensid mindestens eine anionische Gruppe auf.In the context of the present invention, gemini surfactants are surface-active compounds which consist of at least two, preferably two, surfactant units, ie of hydrophilic head group and hydrophobic group, which are identified by at least one, preferably spacer, spacer Near the head group are linked together. The gemini or gemini silk are also called dimer surfactants and bear their name because of their special design. Depending on the nature of the head group, there are anionic, nonionic, cationic and amphoteric gemini surfactants. Different to However, conventional surfactants, which are likewise classified into these groups, gemini surfactants can also carry combinations of head groups of different character. These are usually combinations of nonionic and ionic groups. Preferably, the gemini surfactant has at least one anionic group.

Zu den bevorzugt in den erfindungsgemäßen Tensidzusammensetzungen eingesetzten Geminitensiden zählen solche, die an der Verknüpfungsstelle zwischen Spacer, hydrophiler und hydrophober Gruppe Stickstoffatome enthalten. Dazu gehören bevorzugt Geminitenside mit Amin- oder Amidgruppen aufweisenden Spacern aber auch sich von Dicarbonsäuren ableitende Spacer, sich von Betainstrukturen ableitende, hydrophile Doppelkopfgruppen, die gegebenenfalls durch Alkoxylieren (insbesondere Ethoxylieren) hergestellte Seitengruppen aufweisen, die Sulfonsäure-, Phosphonsäure-, Carbonsäure oder Alkoholgruppen (einschließlich Polyalkoholen) tragen können, und hydrophobe Doppelketten mit 5 bis 25 C-Atomen, die verzweigt oder unverzweigt sein können und bis zu 2 nicht benachbarte Doppelbindungen tragen können.The gemini surfactants preferably used in the surfactant compositions according to the invention include those which contain nitrogen atoms at the point of attachment between spacer, hydrophilic and hydrophobic group. These include preferably gemini surfactants with spacers containing amines or amides, but also spacers deriving from dicarboxylic acids, hydrophilic double head groups derived from betaine structures which optionally have side groups prepared by alkoxylation (in particular ethoxylation), the sulfonic acid, phosphonic acid, carboxylic acid or alcohol groups ( including polyhydric alcohols), and hydrophobic double chains of 5 to 25 carbon atoms, which may be branched or unbranched and may carry up to 2 non-contiguous double bonds.

Die folgenden allgemeine Strukturvarianten der Geminitenside wie durch die Formeln wiedergegeben sind für die erfindungsgemäße Tensidzusammensetzungen besonders geeignet. Die bevorzugten Strukturvarianten werden durch die Definition der Substituenten / Spacer näher erläutert, wobei jede einzelne Definition eines Substituenten / Spacers auch für sich allein genommen das Geminitensid charakterisieren kann. Die Offenbarung der unter A.I bis D.IV genannten Schriften wird hiermit bezüglich der Definition der Geminitenside ausdrücklich zum Inhalt dieser Anmeldung gemacht.The following general structural variants of the gemini surfactants as represented by the formulas are particularly suitable for the surfactant compositions of the invention. The preferred structural variants are explained in greater detail by the definition of the substituents / spacers, wherein each individual definition of a substituent / spacer can also characterize the gemini surfactant taken by itself. The disclosure of the writings mentioned under AI to D.IV is hereby explicitly made the content of this application with regard to the definition of the gemini surfactants.

Variante A: Auf amid- oder aminhaltigen Spacern beruhende Strukturen Variant A: structures based on amide- or amine-containing spacers A.I Geminitenside der allgemeinen Formel (A.I) analog WO 96/14926A.I gemini surfactants of the general formula (A.I) analogous to WO 96/14926

Figure imgb0001

wobei die Substituenten unabhängig voneinander folgende Bedeutung haben:

R1, R3
C5- bis C25-Alkyl, verzweigt oder unverzweigt, gesättigt, gegebenenfalls bis zu 2-fach nicht-benachbart ungesättigt;
R2
C1- bis C12-Alkylen;
X,Y
(C2H4O-)x(C3H6O-)y-FR; x+y ≥ 1, x: 0-15, y: 0-10 und
FR
-SO3M, -CH2-CO2M, -P(O)(OM)2, H, -C3H6SO3M; oder
-CH2(CHOH)4CH2OH, soweit x+y=0; wobei M = ein Gegenion wie Alkali, (Alkyl)Ammonium, Alkanolammonium, H oder ½ Erdalkali ist.
Figure imgb0001

where the substituents independently of one another have the following meanings:
R 1 , R 3
C 5 to C 25 alkyl, branched or unbranched, saturated, optionally up to 2-fold non-adjacent unsaturated;
R 2
C 1 to C 12 alkylene;
X, Y
(C 2 H 4 O-) x (C 3 H 6 O-) y -FR; x + y ≥ 1, x: 0-15, y: 0-10 and
FR
-SO 3 M, -CH 2 -CO 2 M, -P (O) (OM) 2 , H, -C 3 H 6 SO 3 M; or
-CH 2 (CHOH) 4 CH 2 OH, as far as x + y = 0; where M = a counterion such as alkali, (alkyl) ammonium, alkanolammonium, H or ½ alkaline earth.

A.II Geminitenside mit Dicarbonsäure-stämmigen Spacern der allgemeinen Formel (A.II) analog WO 96/25388A.II gemini surfactants with dicarboxylic acid-containing spacers of the general formula (A.II) analogous to WO 96/25388

Figure imgb0002

wobei die Substituenten unabhängig voneinander die für die allgemeine Formel (A.I) angegebene Bedeutung haben.
Figure imgb0002

where the substituents independently of one another have the meaning given for the general formula (AI).

A.III Amphotere Geminitenside der allgemeinen Formel (A.III) analog WO 97/31890A.III Amphoteric gemini surfactants of the general formula (A.III) analogous to WO 97/31890

Figure imgb0003

wobei die Substituenten unabhängig voneinander die für die allgemeine Formel (A.I) angegebene Bedeutung haben. Geminitenside der allgemeinen Formel (A.III) sind amphotere Verbindungen, so daß sie bei entsprechend saurem Umgebungsmedium auch kationisch werden können.
Figure imgb0003

where the substituents independently of one another have the meaning given for the general formula (AI). Gemini surfactants of the general formula (A.III) are amphoteric compounds, so that they can also become cationic in a correspondingly acidic surrounding medium.

Variante B: Auf amid- oder aminhaltigen Spacern beruhende Strukturen Variant B: structures based on amide- or amine-containing spacers B.I Geminitenside der allgemeinen Formel (B.I) analog DE 19622612 oder JP-A 10-175934B.I gemini surfactants of the general formula (B.I) analogous to DE 19622612 or JP-A 10-175934

Figure imgb0004

wobei die Substituenten unabhängig voneinander folgende Bedeutung haben:

R1, R3
C5- bis C25- Alkyl, verzweigt oder unverzweigt, gesättigt, gegebenenfalls bis zu 2-fach nicht-benachbart ungesättigt;
R2
C1- bis C12-Alkylen;
A
CHR4, CH2, C2H4, C3H6, C4H8;
R4
Rest einer Aminocarbonsäure und
M
ein Gegenion wie Alkali, (Alkyl)Ammonium, Alkanolammonium, H oder ½ Erdalkali.
Figure imgb0004

where the substituents independently of one another have the following meanings:
R 1 , R 3
C 5 to C 25 alkyl, branched or unbranched, saturated, optionally up to 2-fold non-adjacent unsaturated;
R 2
C 1 to C 12 alkylene;
A
CHR 4 , CH 2 , C 2 H 4 , C 3 H 6 , C 4 H 8 ;
R 4
Residue of an aminocarboxylic acid and
M
a counterion such as alkali, (alkyl) ammonium, alkanolammonium, H or ½ alkaline earth.

B.II Geminitenside der allgemeinen Formel (B.II) analog EP 0 708 079B.II gemini surfactants of the general formula (B.II) analogous to EP 0 708 079

Figure imgb0005

wobei die Substituenten unabhängig voneinander die für die allgemeine Formel (B.I) angegebene Bedeutung haben und

R5, R6
C6- bis C36-Alkyl, verzweigt oder unverzweigt, gesättigt, gegebenenfalls bis zu 2-fach nicht-benachbart ungesättigt;
X
Alkylen- oder Alkenylengruppe mit 1 bis 6 Kohlenstoffatomen, die mit einer Hydroxylgruppe oder einer Sulfonsäuregruppe oder einer Carboxygruppe substituiert sein kann;
Y1
eine Sulfonat- oder Sulfatgruppe oder eine Carboxylgrupppe und
Y2
eine Hydroxylgruppe, ein Schwefelsäurerest oder -O-(CO)X-COOH bedeuten.
Figure imgb0005

wherein the substituents independently of one another have the meaning given for the general formula (BI) and
R 5, R 6
C 6 to C 36 alkyl, branched or unbranched, saturated, optionally up to 2-fold non-adjacent unsaturated;
X
Alkylene or alkenylene group having 1 to 6 carbon atoms which may be substituted with a hydroxyl group or a sulfonic acid group or a carboxy group;
Y 1
a sulfonate or sulfate group or a carboxyl group and
Y 2
a hydroxyl group, a sulfuric acid residue or -O- (CO) X-COOH.

B.III Geminitenside der allgemeinen Formel (B.III) analog JP-A-8-311003B.III Gemini surfactants of the general formula (B.III) analogous to JP-A-8-311003

Figure imgb0006

wobei die Substituenten unabhängig voneinander die für die allgemeine Formel (B.I) angegebene Bedeutung haben und FG -COOM oder -SO3M bedeutet.
Figure imgb0006

wherein the substituents independently of one another have the meaning given for the general formula (BI) and FG -COOM or -SO 3 M means.

B.IV Geminitenside der allgemeinen Formel (B.IV) analog JP-A 11-60437B.IV Gemini surfactants of the general formula (B.IV) analogous to JP-A 11-60437

Figure imgb0007

wobei die Substituenten unabhängig voneinander, die bei den allgemeinen Formeln (B.I) und (B.II) angegebene Bedeutung haben und

AO
Alkylenoxideinheiten, d.h. Ethylenglykol-, Propylenglykol und Butylenglykolethereinheiten, allein oder statistisch oder blockweise verteilt, mit n = 1 bis 20 und
Z
-SO3M, -C2H4SO3M, -C3H6SO3M, -P(O)(OM)2 oder -CH2-COOM, -C2H4-COOM bedeuten.
Figure imgb0007

wherein the substituents independently of one another have the meaning given in the general formulas (BI) and (B.II) and
AO
Alkylenoxideinheiten, ie ethylene glycol, propylene glycol and Butylenglykolethereinheiten, alone or randomly or in blocks distributed, where n = 1 to 20 and
Z
-SO 3 M, -C 2 H 4 SO 3 M, -C 3 H 6 SO 3 M, -P (O) (OM) 2 or -CH 2 -COOM, -C 2 H 4 -COOM.

B.V Geminitenside der allgemeinen Formel (B.V)B.V Gemini surfactants of the general formula (B.V)

Figure imgb0008

wobei die Substituenten unabhängig voneinander folgende Bedeutung haben:

R1, R3
C5- bis C25- Alkyl, verzweigt oder unverzweigt, gesättigt, gegebenenfalls bis zu 2-fach nicht-benachbart ungesättigt;
R2
C1- bis C12-Alkylen;
M
ein Gegenion wie Alkali, (Alkyl)Ammonium, Alkanolammonium, H oder ½ Erdalkali, wobei die Carbonsäuregruppen auch nur teilweise neutralisiert sein können.
Figure imgb0008

where the substituents independently of one another have the following meanings:
R 1 , R 3
C 5 to C 25 alkyl, branched or unbranched, saturated, optionally up to 2-fold non-adjacent unsaturated;
R 2
C 1 to C 12 alkylene;
M
a counterion such as alkali, (alkyl) ammonium, alkanolammonium, H or ½ alkaline earth, wherein the carboxylic acid groups may also be only partially neutralized.

Variante C: Auf amid- oder aminhaltigen Spacern beruhende Strukturen Variant C: structures based on amide- or amine-containing spacers C.I Geminitenside der allgemeinen Formel (C.I) analog EP 0 697 244C.I Gemini surfactants of the general formula (C.I) analogous to EP 0 697 244

Figure imgb0009

wobei die Substituenten unabhängig voneinander folgende Bedeutung haben:

R1
C5- bis C25-Alkyl, verzweigt oder unverzweigt, gesättigt, gegebenenfalls bis zu 2-fach nicht-benachbart ungesättigt, hydroxysubstituiert oder perfluoriert;
R2
C1- bis C12-Alkylen oder hydroxysubstituierte Derivate davon;
B
eine Amidgruppe [-C(O)N(R2)- oder -N(R5)C(O)-], eine Carboxylgruppe [-C(O)O- oder -OC(O)-], eine Polyethergruppe [-(O(R6-O)x-];
R5
für C1- bis C4-Alkyl oder hydroxysubstituiertes Alkyl oder H steht;
R6
für C2- bis C4-Alkylen;
x
eine Zahl von 1 bis 20;
R3
für C1- bis C12- Alkyl oder hydroxysubstituierte Derivate davon, R7-D-R7 oder eine Polyethergruppe [-(O(R6-O)x-];
R7
für C1- bis C6- Alkylen oder hydroxysubstituierte Derivate davon;
D
-O-, -S-, -N(R8)- ;
R4
Alkylen oder Alkylaryl mit 1 bis 12 C-Atomen oder die hydroxysubstituierten Derivaten oder R9-D1-R9 ;
R8
C1- bis C12-Alkyl oder hydroxysubstituiertes Alkyl oder H oder R9-D1-R9;
R9
für C1- bis C6- Alkylen oder hydroxysubstituierte Derivate davon oder Aryl;
D1
-O-, .-S-, -SO2-, -C(O)-, [-(O(R7-O)x-], (R10)t[N(R10)]z oder Aryl;
R10
C1- bis C12-Alkyl oder hydroxysubstituiertes Alkyl oder H oder Aryl;
t,z
unabhängig voneinander eine Zahl von 1 bis 4 bedeuten und
Y
unabhängig voneinander für -SO3H, O-SO3H, -OP(O)(OH)2, -P(O)(OH)2, -COOH, -CO2-C6H4-SO3H und deren Salze davon steht.
Figure imgb0009

where the substituents independently of one another have the following meanings:
R 1
C 5 - to C 25 -alkyl, branched or unbranched, saturated, optionally up to twice non-adjacent unsaturated, hydroxy-substituted or perfluorinated;
R 2
C 1 to C 12 alkylene or hydroxy substituted derivatives thereof;
B
an amide group [-C (O) N (R 2 ) - or -N (R 5 ) C (O) -], a carboxyl group [-C (O) O- or -OC (O) -], a polyether group [ - (O (R 6 -O) x -];
R 5
is C 1 to C 4 alkyl or hydroxy substituted alkyl or H;
R 6
for C 2 - to C 4 -alkylene;
x
a number from 1 to 20;
R 3
for C 1 to C 12 alkyl or hydroxy substituted derivatives thereof, R 7 -DR 7 or a polyether group [- (O (R 6 -O) x -];
R 7
for C 1 to C 6 alkylene or hydroxy substituted derivatives thereof;
D
-O-, -S-, -N (R 8 ) -;
R 4
Alkylene or alkylaryl having 1 to 12 carbon atoms or the hydroxy-substituted derivatives or R 9 -D 1 -R 9 ;
R 8
C 1 to C 12 alkyl or hydroxy substituted alkyl or H or R 9 -D 1 -R 9 ;
R 9
for C 1 to C 6 alkylene or hydroxy substituted derivatives thereof or aryl;
D 1
-O-,.-S-, -SO 2 -, -C (O) -, [- (O (R 7 -O) x -], (R 10 ) t [N (R 10 )] z or aryl ;
R 10
C 1 to C 12 alkyl or hydroxy substituted alkyl or H or aryl;
t, z
independently represent a number from 1 to 4 and
Y
independently of one another for -SO 3 H, O-SO 3 H, -OP (O) (OH) 2 , -P (O) (OH) 2 , -COOH, -CO 2 -C 6 H 4 -SO 3 H and the salts of which stands.

C.II Geminitenside der allgemeinen Formel (C.II) analog EP 0 697 245C.II Gemini surfactants of the general formula (C.II) analogous to EP 0 697 245

Figure imgb0010

wobei die Substituenten unabhängig voneinander die für die allgemeine Formel (C.I) angegebene Bedeutung haben und

R11
C5- bis C23-Alkyl, verzweigt oder unverzweigt, gesättigt, gegebenenfalls bis zu 2-fach nicht-benachbart ungesättigt, hydroxysubstituiert oder perfluoriert oder R14-B-R2;
R14
C1- bis C12-Alkyl, verzweigt oder unverzweigt, gesättigt, gegebenenfalls bis zu 2-fach nicht-benachbart ungesättigt, oder die hydroxysubstituierten Derivate;
R12
C1- bis C12-Alkylen, verzweigt oder unverzweigt, gesättigt, gegebenenfalls bis zu 2-fach nicht-benachbart ungesättigt, oder die hydroxysubstituierten Derivate oder eine Amidgruppe [-C(O)N(R2)- oder -N(R5)C(O)], eine Carboxylgruppe [-C(O)O- oder -OC(O)-], eine Polyethergruppe [(O(R6-O)x-] oder R9-D1-R9 und
A
-CR6= oder -N= unter der Voraussetzung, daß wenn A gleich -N= ist, R11 gleich R14-B-R2 bedeuten.
Figure imgb0010

wherein the substituents independently of one another have the meaning given for the general formula (CI) and
R 11
C 5 to C 23 alkyl, branched or unbranched, saturated, optionally up to 2-fold non-adjacent unsaturated, hydroxy-substituted or perfluorinated, or R 14 -BR 2 ;
R 14
C 1 to C 12 alkyl, branched or unbranched, saturated, optionally up to 2-fold non-adjacent unsaturated, or the hydroxy-substituted derivatives;
R 12
C 1 - to C 12 -alkylene, branched or unbranched, saturated, optionally up to 2-fold non-adjacent unsaturated, or the hydroxy-substituted derivatives or an amide group [-C (O) N (R 2 ) - or -N (R 5 ) C (O)], a carboxyl group [-C (O) O- or -OC (O) -], a polyether group [(O (R 6 -O) x -] or R 9 -D 1 -R 9 and
A
-CR 6 = or -N =, provided that when A is -N =, R 11 is R 14 -BR 2 .

C.III Geminitenside der allgemeinen Formel (C.III) analog DE 4227391 und DE 19608117C.III Gemini surfactants of the general formula (C.III) analogous to DE 4227391 and DE 19608117

Figure imgb0011

wobei die Substituenten unabhängig voneinander die für die allgemeinen Formeln (C.I) und (C.II) angegebene Bedeutung haben und

R21
C5- bis C23-Alkyl, verzweigt oder unverzweigt, gesättigt, gegebenenfalls bis zu 2-fach nicht-benachbart ungesättigt;
R22, R24
C1- bis C6 Alkylen;
R23
Methyl, Ethyl, Propyl oder eine Polyethergruppe [-(O(R6-O)x-]

bedeuten.
Figure imgb0011

wherein the substituents independently of one another have the meaning given for the general formulas (CI) and (C.II) and
R 21
C 5 to C 23 alkyl, branched or unbranched, saturated, optionally up to 2-fold non-adjacent unsaturated;
R 22 , R 24
C 1 to C 6 alkylene;
R 23
Methyl, ethyl, propyl or a polyether group [- (O (R 6 -O) x -]

mean.

Variante D :Variant D: D. I Geminitenside der allgemeinen Formel (D.I) analog US 5,863,886D. I gemini surfactants of the general formula (D.I) analogously to US Pat. No. 5,863,886

Figure imgb0012

wobei die Substituenten unabhängig voneinander folgende Bedeutung haben:

R, R1
C5- bis C30-Alkyl, verzweigt oder unverzweigt, gesättigt, gegebenenfalls bis zu 2-fach nicht-benachbart ungesättigt, hydroxysubstituiert oder perfluoriert;
R2
C1-bis C10- Alkylen, Arylen und hydroxysubstituierte Derivat, ein Polyether [-O(R4O)x-], -S-, -SO2-, -O-, -S-S-, -O-R5-O- oder ―S-R5-S-; Variable für eine direkte Bindung zwischen den beiden α-Kohlenstoffen;
R4
C2- bis C4-Alkylen;
R5
C1- bis C10-Alkylen, Arylen oder Alkylarylen, -N(R6)- oder -(NR6)-R7-(NR6)- ;
R6
C1- bis C6-Alkyl;
R7
C1- bis C6-Alkyl, wobei R7 und R6 auch Teil eines heterocyclischen Ringes sein können;
X
Polyether [-O(R4O)x-], wobei x eine Zahl von 1 bis 30 ist, -O-, NZ;
Z
C1- bis C10- Alkyl, Aryl, Alkylaryl oder H und
Y, Y1
unabhängig voneinander H, -CH2-COOH und Salze, ein Kohlenwasserstoffrest mit mindestens 2 Hydroxylgruppen, wie Erythrose, Threose, Ribose, Arabinose, Xylose, Fructose, Lyxose, Allose, Altrose, Glucose, Mannose, Galactose und ihre Mischungen.
Figure imgb0012

where the substituents independently of one another have the following meanings:
R, R 1
C 5 - to C 30 -alkyl, branched or unbranched, saturated, optionally up to twice non-adjacent unsaturated, hydroxy-substituted or perfluorinated;
R 2
C 1 to C 10 alkylene, arylene and hydroxy substituted derivative, a polyether [-O (R 4 O) x -], -S-, -SO 2 -, -O-, -SS-, -OR 5 -O - or -SR 5 -S-; Variable for a direct bond between the two α-carbons;
R 4
C 2 to C 4 alkylene;
R 5
C 1 to C 10 alkylene, arylene or alkylarylene, -N (R 6 ) - or - (NR 6 ) -R 7- (NR 6 ) -;
R 6
C 1 to C 6 alkyl;
R 7
C 1 to C 6 alkyl, wherein R 7 and R 6 may also be part of a heterocyclic ring;
X
Polyether [-O (R 4 O) x -], wherein x is a number from 1 to 30, -O-, NZ;
Z
C 1 to C 10 alkyl, aryl, alkylaryl or H and
Y, Y 1
independently of one another H, -CH 2 -COOH and salts, a hydrocarbon radical having at least 2 hydroxyl groups, such as erythrose, threose, ribose, arabinose, xylose, fructose, lyxose, allose, altrose, glucose, mannose, galactose and their mixtures.

D.II Geminitenside der allgemeinen Formel (D.II)D.II Gemini surfactants of the general formula (D.II)

Figure imgb0013

wobei die Substituenten unabhängig voneinander die für die allgemeine Formel (D.I) angegebene Bedeutung haben und

AO
-C(O)-, -C(O)- [-O(R4O)x-], -CH2- [-O(R4O)x-], -CH2-O-;
T, T1
unabhängig voneinander -OM, -H, -CH3, -C2H5, -SO3M, -CH2COOM, -C2H4-COOM, -C3H6-SO3M, -O-P(O)(OM)2 und
M
Alkyli, ½ Erdalkali, Ammonium, Mono-, Di-, Trialkanolammonium oder H bedeuten.
Figure imgb0013

wherein the substituents independently of one another have the meaning given for the general formula (DI) and
AO
-C (O) -, -C (O) - [-O (R 4 O) x -], -CH 2 - [-O (R 4 O) x -], -CH 2 -O-;
T, T 1
independently of one another -OM, -H, -CH 3 , -C 2 H 5 , -SO 3 M, -CH 2 COOM, -C 2 H 4 -COOM, -C 3 H 6 -SO 3 M, -OP (O ) (OM) 2 and
M
Alkyli, ½ alkaline earth, ammonium, mono-, di-, trialkanolammonium or H.

D.III Geminitenside der allgemeinen Formel (D.III) analog WO 96/16930D.III Gemini surfactants of the general formula (D.III) analogous to WO 96/16930

Figure imgb0014

wobei die Substituenten unabhängig voneinander die für die allgemeinen Formeln (D.I) und (D.II) angegebene Bedeutung haben und

R8
NYY1, -O(R4O)xH oder -O(R4O)x-C(O)-CHR-CHR1-C(O)NYY1 bedeutet.
Figure imgb0014

wherein the substituents independently of one another have the meaning given for the general formulas (DI) and (D.II), and
R 8
NYY 1 , -O (R 4 O) x H or -O (R 4 O) x -C (O) -CHR-CHR 1 -C (O) NYY 1 .

D.IV Geminitenside der allgemeinen Formel (D.IV) analog WO 96/25384D.IV Gemini surfactants of the general formula (D.IV) analogous to WO 96/25384

Figure imgb0015

wobei die Substituenten die für die allgemeinen Formeln (D.I), (D.II) und (D.III) angegebene Bedeutung haben und

t
eine ganze Zahl von 1 bis 100, bevorzugt 1 bis 20, besonders bevorzugt 1 bis 4 bedeutet.
Figure imgb0015

wherein the substituents have the meaning given for the general formulas (DI), (D.II) and (D.III), and
t
an integer from 1 to 100, preferably 1 to 20, particularly preferably 1 to 4 means.

Vorzugsweise werden in den Tensidzusammensetzungen als Detergenskomponente mit schlecht schäumender, vorzugsweise milder, Charakteristik folgende Verbindungen eingesetzt:

  • wasserlösliche Zuckertenside, acylierte Protein-Derivate, Sulfosuccinate, insbesondere Natrium- -Mono- und -Di-alkanol-sulfobernsteinsäureester mit verzweigten oder unverzweigten, gesättigten oder 1 bis 3-fach nicht-benachbart ungesättigten Alkylresten im Bereich von C6 bis C18, oder Acyllactylate, insbesondere Natrium-, Kalium-, Magnesium- oder Calciumsalze der an der Hydroxylgruppe mit linearen oder verzweigten, gesättigten oder 1 bis 3-fach nicht-benachbart ungesättigten, cyclischen oder acyclischen Carbonsäuren mit C6 bis C24 veresterter monomerer Milchsäure oder deren Oligomeren, wobei der Oligomerisierungsgrad der Milchsäure vorzugsweise bei 1,1 bis 10, besonders bevorzugt bei 1,1 bis 4 liegt, oder Alkyl(poly)glucoside mit einem Oligomerisierungsgrad von 1,0 bis 10, vorzugsweise 1 bis 3, und Alkylresten, die verzweigt oder unverzweigt, gesättigt oder 1 bis 3-fach nicht-benachbart ungesättigt, cyclisch oder acylisch sind, und 6 bis 24 Kohlenstoffatome enthalten, oder Alkali-, Erdalkali-, Mono-, Di- und Trialkanolammonium-, Ammonium-, Mono-, Di-, Trialkylammoniumsalze N-acylierter Aminosäuren, einschließlich ggf. auch teil-N-acylierter Oligo-/Poly-Aminosäuren, wie der Alkylisethionate, die Alkylreste mit 6 bis 24 Kohlenstoffen enthalten und verzweigt oder unverzweigt, gesättigt oder 1- bis 3-fach nicht-benachbart ungesättigt sind, oder Alkali-, Erdalkali-, Mono-, Di- und Trialkanolammonium-, Ammonium-, Mono-, Di-, Trialkylammoniumsalze der Acylsarcosinate, die Alkylreste mit 6 bis 24 Kohlenstoffen enthalten und verzweigt oder unverzweigt, gesättigt oder 1- bis 3-fach nicht-benachbart ungesättigt sind, oder Proteinkondensate mit C6- bis C24-Acylresten, die verzweigt oder unverzweigt, gesättigt oder 1- bis 3-fach nicht-benachbart ungesättigt sind, oder Betaine, die Alkylketten mit 6 bis 24 Kohlenstoffatomen enthalten, die verzweigt oder linear, gesättigt oder 1- bis 3-fach nicht-benachbart ungesättigt sein können. Bei den Betainen sind solche vom Amidoamin-Typ bevorzugt. Acylglutamate mit 6 bis 24 Kohlenstoffatomen in der Acylkette, die linear oder verzweigt, gesättigt oder 1- bis 3-fach nicht-benachbart ungesättigt sein kann, eignen sich ebenfalls. Besonders bevorzugte weitere Detergenskomponenten für die erfindungsgemäßen Mischungen sind Acyllactylate und Acylglutamate.
The following compounds are preferably used in the surfactant compositions as a detergent component having a poorly foaming, preferably mild, characteristic:
  • water-soluble sugar surfactants, acylated protein derivatives, sulfosuccinates, in particular sodium mono- and di-alkanol-sulfosuccinic acid esters with branched or unbranched, saturated or 1-3 non-adjacent unsaturated alkyl radicals in the range of C 6 to C 18 , or Acyllactylate, in particular sodium, potassium, magnesium or calcium salts of the at the hydroxyl group with linear or branched, saturated or 1 to 3-fold non-adjacent unsaturated, cyclic or acyclic carboxylic acids with C 6 to C 24 esterified monomeric lactic acid or their oligomers, wherein the degree of oligomerization of the lactic acid is preferably 1.1 to 10, particularly preferably 1.1 to 4, or alkyl (poly) glucosides having a degree of oligomerization of 1.0 to 10, preferably 1 to 3, and alkyl radicals which are branched or unbranched, saturated or 1-3 non-adjacent unsaturated, cyclic or acylic, containing from 6 to 24 carbon atoms, or alkali, alkaline earth, mono-, di- and trialkanolammonium, ammonium, mono , Di-, Trialkylammoniumsalze N-acylated amino acids, including optionally also partially N-acylated oligo- / poly-amino acids, such as the Alkylisethionate containing alkyl radicals having 6 to 24 carbons and branched or unbranched, saturated or 1 to 3 are non-adjacent unsaturated, or alkali, alkaline earth, mono-, di- and Trialkanolammonium-, ammonium, mono-, di-, trialkylammonium salts of acylsarcosinates containing alkyl radicals having 6 to 24 carbons and branched or unbranched branched, saturated, or 1-3 non-adjacent unsaturated, or protein condensates having C 6 to C 24 acyl radicals branched or unbranched, saturated, or 1-3 times non-adjacent unsaturated, or betaines, contain the alkyl chains of 6 to 24 carbon atoms, which may be branched or linear, saturated or not monosubstituted to unsaturated 3-fold. In the betaines, amidoamine-type ones are preferred. Acylglutamates having from 6 to 24 carbon atoms in the acyl chain, which may be linear or branched, saturated or non-adjacent to one to three times unsaturated, are also suitable. Particularly preferred further detergent components for the mixtures according to the invention are acyl lactylates and acyl glutamates.

Mild im Sinne der Erfindung bedeutet, daß die entsprechenden Verbindungen / Zusammensetzung kennzeichnungsfrei (z.B. gemäß Richtlinie 67-548-EWG, Gefahrstoffverordnung) hinsichtlich ihres Irritationspotentials für Haut und Augen sind.Mild in the sense of the invention means that the corresponding compounds / compositions are free of labeling (for example according to Directive 67-548-EEC, Hazardous Substances Ordinance) with respect to their irritation potential for skin and eyes.

Unter der Eigenschaft "mit schlecht-schäumender Charakteristik" ist im Sinne der Erfindung zu verstehen, daß diese Tenside in ihrer Eigenschaft als weitere Detergenskomponente zwei von drei der unten aufgeführten Werte bei der Beurteilung ihres Schaumbildungsverhaltens unterschreiten.For the purposes of the invention, the "poor foaming characteristic" property means that these surfactants, in their capacity as further detergent component, fall short of two of the three values listed below in the evaluation of their foaming behavior.

Die Kriterien sind

  • die Schaumlamellendicke in mm direkt nach der Schaumherstellung,
  • der Blasenzahl pro Bildfläche bei 100facher Vergrößerung direkt nach der Herstellung, beide durch die Mikroskopie des Schaumes bestimmt, und
  • das Anschäumverhalten im Handversuch.
The criteria are
  • the foam lamella thickness in mm directly after foam production,
  • the number of bubbles per image area at 100x magnification directly after production, both determined by the microscopy of the foam, and
  • the foaming behavior in the hand test.

Unter der Eigenschaft "mit schlecht-schäumender Charakteristik" ist im Sinne der Erfindung zu verstehen, daß diese Tenside in ihrer Eigenschaft als weitere Detergens-Komponente zwei von drei der unten aufgeführten Werte bei der Beurteilung ihres Schaumbildungsverhaltens unterschreiten.For the purposes of the invention, the "poor foaming characteristic" property means that these surfactants, in their capacity as further detergent components, fall short of two of the three values listed below in the evaluation of their foaming behavior.

Die Kriterien sind die

  • Schaumlamellendicke in mm direkt nach der Schaumherstellung,
  • der Blasenzahl pro Bildfläche bei 100facher Vergrößerung direkt nach der Herstellung, beide durch die Mikroskopie des Schaumes bestimmt, und
  • das Anschäumverhalten im Handversuch.
The criteria are the
  • Foam lamella thickness in mm directly after foam production,
  • the number of bubbles per image area at 100x magnification directly after production, both determined by the microscopy of the foam, and
  • the foaming behavior in the hand test.

Versuchsdurchführung zur Bestimmung der Eigenschaft "mit schlecht-schäumender Charakteristik":Carrying out the experiment to determine the property "with poor foaming characteristics":

8 Gew.-% des zu charakterisierenden Tensids werden in demineralisiertem Wasser gelöst. Die zu untersuchende Tensidlösung wird 10 min. bei 1500 U/min mit Apparatur mit Blattrührer gemäß Figur 2/3 bis 4/4 gerührt, wobei sich die Lösung etwas erwärmt (von Raumtemperatur auf ca. 35°C). Nach 10 Minuten Rührzeit wird der entstandene Schaum von oben abgeschöpft und direkt mikroskopiert - hierbei wird die Lamellendicke in mm gemessen und die Anzahl der Schaumblasen im Bildausschnitt bestimmt.8% by weight of the surfactant to be characterized are dissolved in demineralized water. The surfactant solution to be examined is 10 min. stirred at 1500 rev / min with apparatus with blade stirrer according to Figure 2/3 to 4/4, wherein the solution is slightly heated (from room temperature to about 35 ° C). After stirring for 10 minutes, the resulting foam is skimmed off from above and subjected to direct microscopy - in this case the lamella thickness is measured in mm and the number of foam bubbles in the image section is determined.

Neben der durch Rühren erzeugten Schaumqualität wird auch das Anschäumverhalten eines Tensids unter fließendem kalten Leitungswasser beurteilt. Hierzu werden 2 g Tensid auf die Innenhandflächen verteilt und unter fließendem Wasser gleichmäßig verrieben. Die Schaumqualität wird in vier Stufen beurteilt, 0 = keine Schaumbildung, 1 = mäßige Schaumbildung, 2 = gute Schaumbildung und 3 = sehr gute Schaumbildung.In addition to the foaming quality generated by stirring, the foaming behavior of a surfactant under flowing cold tap water is also assessed. For this purpose, 2 g of surfactant are distributed on the palm of your hand and rubbed evenly under running water. The foam quality is assessed in four stages, 0 = no foaming, 1 = moderate foaming, 2 = good foaming and 3 = very good foaming.

Als schlecht schäumend werden Tenside beurteilt, wenn sie die Grenzen von mindestens zwei der drei unten genannten Kriterien unterschreiten, d.h.

  • Lamellendicken kleiner oder gleich 16 mm aufweisen oder
  • kleiner oder gleich 16 Blasen im Bildausschnitt aufweisen oder
  • im Anschäumverhalten mit 1 oder schlechter beurteilt werden.
Surfactants are considered to be poorly foaming if they fall below the limits of at least two of the three criteria listed below, ie
  • Have lamella thicknesses of less than or equal to 16 mm or
  • have less than or equal to 16 bubbles in the image section or
  • be judged in the foaming with 1 or worse.

Als gut schäumend werden Tenside beurteilt, wenn sie alle drei Kriterien mit Werten von ≥ 20 mm in der Lamellendicke, ≥ 20 Blasen im Bildausschnitt (beides direkt nach dem Anschäumen) und ein mit 3 beurteiltes Anschäumverhalten aufweisen.Surfactants are judged to be good foaming if they have all three criteria with values of ≥ 20 mm in the lamella thickness, ≥ 20 bubbles in the image section (both directly after foaming) and a foaming behavior rated 3.

Das verwendete Verfahren zur Schaumherstellung ist in Fig. 2 bis 4 schematisch dargestellt. Die Zeichnung zeigt schematisch in Fig. 2 den verwendeten Blattrührer zur Schaumherstellung, in Fig. 3 den Versuchsaufbau zur Schaumherstellung -jeweils mit den Größenangaben in cm, wobei H die Höhe der ungeschäumten Lösung ist -, und in Fig. 4 den Zustand nach Aufschäumen bei einer Umfangsgeschwindigkeit des Blattrührers von 5 m/sec. (S = Schaum, D = Detergenslösung). Nach 10 Minuten Rührzeit wurde der entstandene Schaum von oben abgeschöpft und sowohl direkt als auch nach 2, 5 und 15 Minuten mikroskopiert. Für alle Untersuchungen wurde folgender Versuchsaufbau gewählt, um den Einfluß der Tensidmischungen auf das Schaumbildungsverhalten zu evaluieren:The method used for foam production is shown schematically in FIGS. 2 to 4. The drawing shows schematically in Fig. 2 the blade stirrer used for foam production, in Fig. 3 the experimental setup for foam production - each with the size in cm, where H is the height of the unfoamed solution -, and in Fig. 4 the state after foaming at a peripheral speed of Blattrührers of 5 m / sec. (S = foam, D = detergent solution). After stirring for 10 minutes, the resulting foam was skimmed off from above and microscopically examined both directly and after 2, 5 and 15 minutes. The following experimental setup was chosen for all investigations in order to evaluate the influence of the surfactant mixtures on the foaming behavior:

Das Verfahren zur Schaumherstellung ist auch in der Deutschen Patentanmeldung 199 43 681 beschrieben, deren Offenbarungsgehalt hiermit auch zum Gegenstand dieser Anmeldung gemacht wird.The process for producing foam is also described in German Patent Application 199 43 681, the disclosure of which is hereby also made the subject of this application.

Als elektrolytstabile anionische Tenside sind die folgenden Verbindungen besonders für das erfindungsgemäße Perlglanzkonzentrat geeignet:

  • Alkylsarcosinate, Alkanolethersulfate, Alkanolsulfate, Alkyltaurate und -isethionate, Sulfobetaine, Olefinsulfonate, Ethercarbonsäuren und deren Salze sowie Alkanolphosphorsäureester und deren Salze, wobei die Alkylketten 8 bis 22 C-Atome enthalten.
As electrolyte-stable anionic surfactants , the following compounds are particularly suitable for the pearlescent concentrate according to the invention:
  • Alkyl sarcosinates, alkanol ether sulfates, alkanol sulfates, alkyl taurates and isethionates, sulfobetaines, olefin sulfonates, ether carboxylic acids and their salts, and alkanol phosphoric acid esters and their salts, the alkyl chains containing from 8 to 22 carbon atoms.

Die folgenden nichtionischen Tenside sind für die Herstellung der erfindungsgemäßen Perlglanzkonzentrate besonders geeignet:

  • Anlagerungsprodukte von 2 bis 30 Mol Ethylenoxid und / oder 0 bis 5 Mol Propylenoxid an lineare Alkylalkohole mit 6 bis 22 C-Atomen, an Fettsäuren mit 6 bis 22 C-Atomen, an Alkylphenole mit 8 bis 15 C-Atomen in der Alkylgruppe und an Mono-, Di- und Triglyceride. C12- bis C18-Fettsäuremono- und -diester von Anlagerungsprodukten von 1 bis 30 Mol Ethylenoxid an Glycerin, Sorbitanmono- und -diester von gesättigen und ungesättigten Fettsäuren mit 6 bis 22 C-Atomen und deren Ethylenoxidanlagerungsprodukten, Alkylmono- und -oligoglycoside mit 6 bis 22 C-Atomen im Alkylrest und deren ethoxylierte Analoga. Anlagerungsproducte von 2 bis 60 Mol Ethylenoxid an Ricinusöl und / oder gehärtetes Ricinusöl, Polyol- und Polyglycerinester, wie z.B. Polyglycerinpolyricinoleat, Polyglcerindimerate oder Polyglycerinpoly-12-hydroxystearat und Gemische dieser Substanzklassen. Partialester auf Basis linearer, verzweigter, ungesättigter bzw. gesättigter C6- bis C22-Fettsäuren, Ricinolsäure sowie 12-Hydroxystearinsäure und Glycerin, Polyglycerin, Pentaerythrit, Dipentaerythrit, Zuckeralkohole (z.B. Sobit), Alkylglucoside sowie Polyglucoside (z.B. Cellulose). Trialkylphosphate sowie Mono-, Di- und / oder Tri-PEG-alkylphosphate, Wollwachsalkohole, Polysiloxan-Polyalkyl-Copolymere bzw. entsprechender Derivate. Mischester aus Pentaerythrit, Fettsäuren, Citronensäure und Fettalkohol und / oder Mischester von Fettsäuren mit 6 bis 22 C-Atomen, Methylglucose und Polyolen, vozugsweise Glycerin sowie Polyalkylenglykole.
The following nonionic surfactants are particularly suitable for the preparation of the pearlescent concentrates according to the invention:
  • Addition products of 2 to 30 moles of ethylene oxide and / or 0 to 5 moles of propylene oxide to linear alkyl alcohols having 6 to 22 carbon atoms, to fatty acids having 6 to 22 carbon atoms, to alkylphenols having 8 to 15 carbon atoms in the alkyl group and on Mono-, di- and triglycerides. C12 to C18 fatty acid mono- and diesters of addition products of 1 to 30 moles of ethylene oxide with glycerol, sorbitan mono- and diesters of saturated and unsaturated fatty acids having 6 to 22 carbon atoms and their ethylene oxide addition products, alkyl mono- and oligoglycosides with 6 to 22 C atoms in the alkyl radical and their ethoxylated analogues. Addition products of 2 to 60 moles of ethylene oxide with castor oil and / or hydrogenated castor oil, polyol and polyglycerol esters, such as Polyglycerinpolyricinoleat, Polyglcerindimerate or Polyglycerinpoly-12-hydroxystearate and mixtures of these classes. Partial esters based on linear, branched, unsaturated or saturated C6- to C22-fatty acids, ricinoleic acid and 12-hydroxystearic acid and glycerol, polyglycerol, Pentaerythritol, dipentaerythritol, sugar alcohols (eg, Sobit), alkylglucosides, and polyglucosides (eg, cellulose). Trialkylphosphates and mono-, di- and / or tri-PEG-alkyl phosphates, wool wax alcohols, polysiloxane-polyalkyl copolymers or corresponding derivatives. Mixed esters of pentaerythritol, fatty acids, citric acid and fatty alcohol and / or mixed esters of fatty acids having 6 to 22 carbon atoms, methyl glucose and polyols, preferably glycerol and polyalkylene glycols.

Besonders bevorzugt sind Alkoholethoxylate mit 6 bis 13 C-Atomen und 4 bis 15 Mol Ethylenoxid, z.B. MARLIPAL ® O13/120, Laureth-9 oder MARLIPAL ® 1012/6, und andere nichtionische Tenside mit vergleichbarem HLB und einer Molmasse < 800 g / Mol.Particularly preferred are alcohol ethoxylates having 6 to 13 carbon atoms and 4 to 15 moles of ethylene oxide, e.g. MARLIPAL® O13 / 120, Laureth-9 or MARLIPAL® 1012/6, and other nonionic surfactants with comparable HLB and a molecular weight <800 g / mol.

Als perlglanzgebende Komponente im erfindungsgemäßen Perlglanzkonzentrat sind die folgenden Verbindungen besonders geeignet:

  • Metallseifen von C12- bis C22-Fettsäuren, z.B. Magnesiumstearat, Mg-, Zn-, Cu- Al- oder Ti-Salze in Kombination mit einer vorgenannten Fettsäure, C12- bis C22-Fettsäuren, langkettige Alkylalkohole mit 18 bis 36 C-Atomen, Alkylalkoholether aus C8- bis C22-Alkylalkoholen, Fettketone mit insgesamt mindestens 18 C-Atomen, Alkanolamide auf der Basis von C10- bis C22-Carbonsäuren und Monoethanolamin, Mono- oder Diester von Glycerin oder Ethylenglykol oder 1,2-Propylenglykol, Butylenglykol, Hexylenglykol und / oder Polyethylenglykol mit einem durchschnittlichen Molekulargewicht von 80 bis 1.000 g / Mol und C12- bis C36-Carbonsäuren. Bevorzugt sind Mono-bis Triethylenglykol-mono- und -distearate, ganz besonders geeignet sind die Monostearate des Mono-, Di- und Triethylenglykols.
As pearlescing component in the pearlescent concentrate according to the invention, the following compounds are particularly suitable:
  • Metal soaps of C12 to C22 fatty acids, for example magnesium stearate, Mg, Zn, CuAl or Ti salts in combination with one of the abovementioned fatty acids, C12 to C22 fatty acids, long-chain alkyl alcohols having 18 to 36 carbon atoms, Alkyl alcohol ethers of C8- to C22-alkyl alcohols, fatty ketones having a total of at least 18 carbon atoms, alkanolamides based on C10- to C22-carboxylic acids and monoethanolamine, mono- or diesters of glycerol or ethylene glycol or 1,2-propylene glycol, butylene glycol, hexylene glycol and / or polyethylene glycol having an average molecular weight of 80 to 1,000 g / mol and C12 to C36 carboxylic acids. Preference is given to mono- to triethylene glycol mono- and distearates, very particularly suitable are the monostearates of mono-, di- and triethylene glycol.

Unter den erfindungsgemäßen Aktivstoffen sind besonders reduktions- oder oxidationsempfindliche Stoffe, in Wasser und Öl besonders schwer lösliche Stoffe oder besonders hydrolyseempfindliche oder tensidempfindliche Stoffe zu verstehen. Besonders geeignet sind hier Antioxidantien, Vitamine (besonders Tocopherol, Retinol) und ihre Derivate, wie besonders ihre Ester, Enzyme, Proteine und Pheromone. Au-ßerdem eignen sich auch Stoffe, die aufgrund ihrer Acidität Probleme in der Formulierung bereiten können, wie beispielsweise α-Hydroxysäuren. Darüber hinaus sind organische UV-Absorber, Hautbräunungsmittel, z.B. Dihydroxyaceton, Geruchsstoffe, beispielsweise zur Parfümierung oder zur Insektenabwehr, wie besonders Thiole, ternäre oder cyclische Amine, natürliche Essenzen, deren insektenabstoßende Wirkung bekannt ist, z.B. Citronen- oder Orangenterpene, Neem-Öl Extrakt oder insektenabstoßende Pheromone zum Einschluß in das Perlglanzkonzentrat geeignet. Weiter geeignet sind essentielle Öle, Aroma- oder auch Farbstoffe.The active substances according to the invention are substances which are particularly sensitive to reduction or oxidation, substances which are particularly sparingly soluble in water and oil or substances which are particularly sensitive to hydrolysis or surfactants. Particularly suitable here are antioxidants, vitamins (especially tocopherol, retinol) and their derivatives, especially their esters, enzymes, proteins and pheromones. In addition, substances which due to their acidity can cause problems in the formulation, such as α-hydroxy acids, are also suitable. In addition, organic UV absorbers, skin tanning agents, eg dihydroxyacetone, odorous substances, for example for perfuming or insect repellent, such as especially thiols, ternary or cyclic amines, natural essences whose insect repellent effect is known, for example citric or orange terpene, neem oil extract or insect repellent pheromones suitable for inclusion in the pearlescent concentrate. Also suitable are essential oils, flavorings or dyes.

Wird auf die Kombination Geminitensid / schlecht schäumende Detergents-Komponente verzichtet, kann es bei ungenügender Stabilität der Aktivstoffe notwendig werden, Agenzien zur Stabilisierung der lamellaren Schichten zuzusetzen (Stabilisatoren). Besonders geeignet sind hier Cholesterin und seine Derivate sowie Phytosterine und deren Derivate sowie gesättigten oder ungesättigte Fettsäuren, insbesondere C12- bis C22- Fettsäuren. Weiterhin können die folgenden hydrophilen Verbindungen in beiden Fällen als Stabilisator eingesetzt werden, wobei nachgenannte Verbindungen zusätzlich eine bessere Fließfähigkeit der erfindungsgemäßen Zusammensetzungen gewährleisten: Glycerin oder Ethylenglykol oder 1,2-Propylenglykol, Butylenglykol, Hexylenglykol und / oder Polyethylenglykol mit einem durchschnittlichen Molekulargewicht von 80 bis 1.000 g / Mol.If the combination gemini surfactant / poor foaming detergent component is dispensed with, it may be necessary in the case of insufficient stability of the active ingredients to add agents for stabilizing the lamellar layers (stabilizers) . Particularly suitable here are cholesterol and its derivatives as well as phytosterols and their derivatives as well as saturated or unsaturated fatty acids, in particular C 12 to C 22 fatty acids. Furthermore, the following hydrophilic compounds can be used in both cases as a stabilizer, wherein said compounds additionally ensure better flowability of the compositions of the invention: glycerol or ethylene glycol or 1,2-propylene glycol, butylene glycol, hexylene glycol and / or polyethylene glycol having an average molecular weight of 80 bis 1,000 g / mol.

Herstellung:production:

Die erfindungsgemäßen Perlglanzkonzentrate können hergestellt werden, in dem die Komponenten (A), (B), (C), (D) und (E) bei 20 bis 80 °C bevorzugt bei 40 bis 50 °C, gemischt werden und bei 30 bis 80 °C, bevorzugt bei 40 bis 50 °C Wasser zugesetzt wird. Der Perlglanzeffekt stellt sich bei 25 bis 30 °C ein und ist bei Temperaturen bis zu 60 °C stabil. Das fertige Perlglanzkonzentrat kann der Anwendungsformulierung bei Raumtemperatur beigemischt werden.The pearlescent concentrates according to the invention can be prepared by mixing the components (A), (B), (C), (D) and (E) at 20 to 80 ° C, preferably at 40 to 50 ° C, and at 30 to 80 ° C, preferably at 40 to 50 ° C water is added. The pearlescent effect sets in at 25 to 30 ° C and is stable at temperatures up to 60 ° C. The finished pearlescent concentrate can be mixed with the application formulation at room temperature.

Die Beurteilung des Perlglanzes erfolgt auf einer Skala von 1 = brillant bis 5 = stumpf, mit Hilfe des Mikroskops wird auf vorhandene Kristalle geprüft (0 = keine Kristalle, 1 = Kristalle sichtbar). Darüber hinaus wird überprüft, ob die gestreckten multilamellaren Schichten von Wasser oder einem in den Anwendungsformulierungen häufig verwendeten Tensid (Alkoholethersulfate, Cocoamidopropylbetain) auf- bzw. angelöst werden (1 = ja, 0 = nein).The pearlescence is assessed on a scale of 1 = brilliant to 5 = blunt, using the microscope is tested for existing crystals (0 = no crystals, 1 = crystals visible). In addition, it is checked whether the stretched multilamellar layers of water or a surfactant frequently used in the application formulations (alcohol ether sulfates, Cocoamidopropylbetain) are dissolved or dissolved (1 = yes, 0 = no).

Die temperaturabhängige Viskosität der Konzentrate wird bestimmt, um die Temperaturbeständigkeit der Konzentrate zu prüfen.The temperature-dependent viscosity of the concentrates is determined to check the temperature stability of the concentrates.

Beispiele für erfindungsgemäße Perlglanzkonzentrate sind folgende tabellarisch zusammengestellte Zusammensetzungen: [CTFA INCI] Formulierung A [Gew.%] B [Gew.%] PEG-3 Stearate 10 10 Laureth-9 18 0 Isotrideceth-13 0 18 Sodium Lauroyl Lactylate, Sodium, Dicocoylethylenediamine PEG-15 sulfate (Geminitensid - Diamidethersulfat) (CERALUTION ® F) 10 10 PEG-400 8 8 Aqua 54 54 [CTFA INCI] Formulierung C [Gew.%] D [Gew.%] Glykol Stearate 10 10 Laureth-9 18 0 Isotrideceth-13 0 18 Sodium Lauroyl Lactylate, Sodium Dicocoylethylenediamine PEG-15 sulfate (Geminitensid - Diamidethersulfat) 10 10 PEG-400 8 8 Aqua 54 54 [CTFA INCI] Formulierung E [Gew.%] F [Gew.%] PEG-3 Stearate 10 10 Laureth-9 18 0 Isotrideceth-13 0 18 Sodium Lauroyl Lactylate, Sodium Dicocoylethylenediamine PEG-15 sulfate (Geminitensid - Diamidethersulfat) 10 10 PEG-400 8 8 Aqua 53 53 Tocopherol 1,0 0 Retinol 0 1,0 [CTFA INCI] Formulierung G [Gew.%] PEG-3 Stearate 10 Laureth-9 20 Isotrideceth-13 0 Sodium Lauroyl Lactylate, Sodium Dicocoylethylenediamine PEG-15 sulfate (Geminitensid - Diamidethersulfat) 10 PEG-400 8 Aqua 49 Ascorbyl Dipalmitate 3 Examples of pearlescent concentrates according to the invention are the following table compositions: [CTFA INCI] formulation A [weight%] B [weight%] PEG-3 stearates 10 10 Laureth-9 18 0 Isotrideceth-13 0 18 Sodium Lauroyl Lactylate, Sodium, Dicocoylethylenediamine PEG-15 sulfate (Geminitensid - Diamide ether sulfate) (CERALUTION® F) 10 10 PEG-400 8th 8th Aqua 54 54 [CTFA INCI] formulation C [weight%] D [% by weight] Glycol stearate 10 10 Laureth-9 18 0 Isotrideceth-13 0 18 Sodium Lauroyl Lactylate, Sodium Dicocoylethylenediamine PEG-15 sulfate (Gemini surfactant - Diamide Ether Sulfate) 10 10 PEG-400 8th 8th Aqua 54 54 [CTFA INCI] formulation E [% by weight] F [weight%] PEG-3 stearates 10 10 Laureth-9 18 0 Isotrideceth-13 0 18 Sodium Lauroyl Lactylate, Sodium Dicocoylethylenediamine PEG-15 sulfate (Gemini surfactant - Diamide Ether Sulfate) 10 10 PEG-400 8th 8th Aqua 53 53 tocopherol 1.0 0 retinol 0 1.0 [CTFA INCI] formulation G [weight%] PEG-3 stearates 10 Laureth-9 20 Isotrideceth-13 0 Sodium Lauroyl Lactylate, Sodium Dicocoylethylenediamine PEG-15 sulfate (Gemini surfactant - diamided ether sulfate) 10 PEG-400 8th Aqua 49 Ascorbyl dipalmitate 3

Die Fähigkeit der erfindungsgemäßen Zusammensetzungen Aktivstoffe wirkungsvoll zu verkapseln wird kann z.B. durch den pH-Verlauf bei Lagerung der Formulierung G und jeweils gleicher Menge Ascorbyl Dipalmitat in Wasser nachgewiesen werden (siehe Diagramm 1/1). Der signifikante Abfall des pH-Wertes zeigt die Hydrolyse des Ascorbyldipalmitates an. Ist dieser Ester, wie in Formulierung G verkapselt, findet keine signifikante Hydrolyse statt.The ability of the compositions of the invention to effectively encapsulate active agents can be e.g. can be detected by the pH during storage of the formulation G and in each case the same amount of ascorbyl dipalmitate in water (see diagram 1/1). The significant drop in pH indicates the hydrolysis of the ascorbyl dipalmitate. If this ester is encapsulated as in Formulation G, there is no significant hydrolysis.

Claims (8)

  1. Surfactant composition comprising an aqueous, flowable pearly luster concentrate in a concentration of 0.5 to 10 % by weight, wherein the pearly luster concentrate comprises
    (A) 5 to 30 % by weight of an anionic surfactant component consisting of
    (A1) one or more anionic gemini surfactants and one or more anionic detergent components having a poor-foaming characteristic and/or
    (A2) one or more electrolyte-stable anionic surfactants,
    (B) 5 to 30 % by weight of one or more non-ionic surfactants, and
    (C) 5 to 30 % by weight of one or more pearl luster giving components, and optionally, one or both of the following components:
    (D) 0 to 50 % by weight of one or more active substances, and
    (E) 0 to 20 % by weight of one or more stabilisers to stabilize the lamellar layers each related to the pearly luster concentrate,

    wherein the gemini surfactants are surface active compounds consisting of at least two surfactant units, namely out of a hydrophilic head group and hydrophobic group, linked with each other by at least one spacer near the head group.
  2. The surfactant composition according to claim 1 comprising the pearly luster concentrate with (D) one or more active substances.
  3. The surfactant composition according to claim 1 comprising 0.1 to 10 % by weight, related to the pearly luster concentrate, of component (D).
  4. The surfactant composition according to any of claims 1 to 3 characterized in that the surfactant composition comprises multilamellar, liquid-crystalline layers.
  5. The surfactant composition according to any of claims 1 to 3 wherein component (A) consists solely of (A1) one or more anionic gemini surfactants and one or more anionic detergent components having a poor-foaming characteristic.
  6. Use of an aqueous, flowable pearly luster concentrate comprising an anionic surfactant component consisting of
    (A1) one or more anionic gemini surfactants and one or more anionic detergent components having a poor-foaming characteristic and/or
    (A2) one or more electrolyte-stable anionic surfactants,
    (B) one or more non-ionic surfactants, and
    (C) one or more pearl luster giving components, and
    (D) one or more active substances,
    and optionally
    (E) one or more stabilisers,

    wherein the gemini surfactants are surface active compounds consisting of at least two surfactant units, namely out of a hydrophilic head group and hydrophobic group, linked with each other by at least one spacer near the head group,
    for the manufacture of a surfactant composition comprising an aqueous, flowable pearly luster concentrate in a concentration of 0.1 to 75 % by weight, wherein in the surfactant composition the active substance is encapsulated in the pearl luster and the pearly luster concentrate forms multilamellar liquid crystal layers.
  7. Use of an aqueous, flowable pearly luster concentrate according to claim 6 wherein the component (A) consists solely of (A1) one or more anionic gemini surfactants and one or more anionic detergent components having a poor-foaming characteristic.
  8. Use of an aqueous, flowable pearly luster concentrate according to claim 6, wherein the surfactant composition comprises the pearly luster concentrate in a concentration of 0.5 to 10 % by weight.
EP01929292A 2000-03-31 2001-04-02 Pearly luster concentrates Expired - Lifetime EP1268723B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10015992 2000-03-31
DE10015992A DE10015992A1 (en) 2000-03-31 2000-03-31 Aqueous pearly luster concentrate comprises anionic surfactant component comprising anionic gemini surfactant(s) and poorly foaming anionic detergent component, nonionic surfactant and pearl luster component
PCT/DE2001/001246 WO2001074979A1 (en) 2000-03-31 2001-04-02 Pearly luster concentrates

Publications (2)

Publication Number Publication Date
EP1268723A1 EP1268723A1 (en) 2003-01-02
EP1268723B1 true EP1268723B1 (en) 2006-03-08

Family

ID=7637084

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01929292A Expired - Lifetime EP1268723B1 (en) 2000-03-31 2001-04-02 Pearly luster concentrates

Country Status (11)

Country Link
US (1) US20040033913A1 (en)
EP (1) EP1268723B1 (en)
JP (1) JP2003529670A (en)
CN (1) CN1277913C (en)
AT (1) ATE319795T1 (en)
AU (1) AU2001256131A1 (en)
BR (1) BR0109591A (en)
DE (2) DE10015992A1 (en)
ES (1) ES2258526T3 (en)
HK (1) HK1054049B (en)
WO (1) WO2001074979A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2390247B (en) * 2002-06-28 2006-04-12 Dwight Cavendish Systems Ltd An improved method and apparatus for providing an anti-copy video signal
EP1560910A1 (en) * 2002-11-14 2005-08-10 The Procter & Gamble Company Rinse aid containing encapsulated glasscare active salt
US8790668B2 (en) 2003-05-08 2014-07-29 The Procter & Gamble Company Personal care compositions that deposit shiny particles
US8147853B2 (en) 2005-02-15 2012-04-03 The Procter & Gamble Company Personal care compositions containing hydrophobically modified non-platelet particles
DE102005019431A1 (en) * 2005-04-25 2006-10-26 Eckart Gmbh & Co. Kg Non-dusty powder pigment composition, useful in e.g. printing colors and varnishes, comprises a radiant pearl pigment, nonionic monomer crosslinking agent and/or nonionic polysiloxane based crosslinking agent and a solvent
JP2006225369A (en) * 2005-08-17 2006-08-31 Asahi Kasei Chemicals Corp Pearl-like detergent
FR2905855B1 (en) * 2006-09-15 2008-11-21 Oreal COSMETIC COMPOSITION COMPRISING ASCORBIC ACID
US9555167B2 (en) * 2006-12-11 2017-01-31 3M Innovative Properties Company Biocompatible antimicrobial compositions
US20080200890A1 (en) * 2006-12-11 2008-08-21 3M Innovative Properties Company Antimicrobial disposable absorbent articles
US8580860B2 (en) * 2007-02-23 2013-11-12 Gojo Industries, Inc. Foamable alcoholic composition
EP1975225B1 (en) * 2007-03-20 2011-11-09 The Procter & Gamble Company Method of cleaning laundry or hard surfaces
FR2956579B1 (en) 2010-02-24 2012-02-10 Oreal COMPOSITION COMPRISING A SUPERABSORBENT AND GEMINE SURFACTANT POLYMER
FR2989886B1 (en) 2012-04-26 2016-12-09 Oreal COMPOSITION COMPRISING SILANE AND GEMINE SURFACTANT
WO2014070689A1 (en) 2012-10-29 2014-05-08 The Procter & Gamble Company Personal care compositions having a tan delta of 0.30 or more at 10°c

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57165308A (en) * 1981-04-03 1982-10-12 Lion Corp Production of pearlescent dispersion
JPS606693B2 (en) * 1982-05-28 1985-02-20 花王株式会社 Method for producing pearlescent agent dispersion
US5540853A (en) * 1994-10-20 1996-07-30 The Procter & Gamble Company Personal treatment compositions and/or cosmetic compositions containing enduring perfume
US5560873A (en) * 1994-12-30 1996-10-01 Chen; Pu Mild cold pearlizing concentrates
DE19616096A1 (en) * 1996-04-23 1997-11-06 Huels Chemische Werke Ag Use of anionic gemini surfactants in formulations for washing, cleaning and personal care products
DE19622612C1 (en) * 1996-06-05 1997-10-23 Henkel Kgaa Gemini surfactants having excellent surface-active properties
DE19622968C2 (en) * 1996-06-07 2000-08-17 Cognis Deutschland Gmbh Aqueous pearlescent concentrates
WO1998000501A1 (en) * 1996-06-28 1998-01-08 The Procter & Gamble Company Detergent composition comprising dianionic cleaning agent and an enzyme
EP0907702A1 (en) * 1996-06-28 1999-04-14 The Procter & Gamble Company Liquid cleaning compositions and shampoos containing dianionic or alkoxylated dianionic surfactants
DE19646882C2 (en) * 1996-11-13 1998-09-24 Henkel Kgaa Aqueous pearlescent concentrates
US5863886A (en) * 1997-09-03 1999-01-26 Rhodia Inc. Nonionic gemini surfactants having multiple hydrophobic and hydrophilic sugar groups

Also Published As

Publication number Publication date
CN1277913C (en) 2006-10-04
EP1268723A1 (en) 2003-01-02
DE10015992A1 (en) 2001-10-18
BR0109591A (en) 2003-02-04
HK1054049B (en) 2007-04-27
DE50109158D1 (en) 2006-05-04
CN1419594A (en) 2003-05-21
AU2001256131A1 (en) 2001-10-15
HK1054049A1 (en) 2003-11-14
WO2001074979A1 (en) 2001-10-11
ATE319795T1 (en) 2006-03-15
JP2003529670A (en) 2003-10-07
ES2258526T3 (en) 2006-09-01
US20040033913A1 (en) 2004-02-19

Similar Documents

Publication Publication Date Title
EP1420749B1 (en) Sprayable o/w emulsions of a low viscosity
EP2550347B1 (en) Use of cleaning agents containing microemulsions that contain wax
EP1268723B1 (en) Pearly luster concentrates
EP0967971B1 (en) Cosmetic preparations
EP0939610A1 (en) Cosmetic preparations
DE19641274C1 (en) Oil in water microemulsion sun protection cosmetic products
EP0300379A2 (en) Nacreous concentrate without alkanol amide
EP1131393A1 (en) Tenside composition containing gemini tensides and use thereof for cleaning skin and hair
DE19543633C2 (en) Cosmetic and / or pharmaceutical preparations
WO2016066299A1 (en) Oil-based exfoliating cleansing product
DE4439091A1 (en) Surfactants
WO1996029981A1 (en) Pearly lustre concentrate with newtonian viscosity
DE19705862C1 (en) Production of surfactant concentrate with pearly lustre for cosmetics, shampoo or shower gel
WO2017012738A1 (en) Two-phase products that can be reversibly mixed and segregated
DE102014224216A1 (en) Cosmetic bar soaps containing soap and microemulsions
EP0445159A1 (en) Surface active mixtures
EP3458024B1 (en) Aqueous tenside compositions
EP3130330B1 (en) Oil based cleaning product with particulates
WO1996030475A1 (en) Pearly lustre concentrates
EP3930675B1 (en) Glycolipid containing cleansing composition comprising micelles
DE19545136C1 (en) Syndet soap bars with little or no free fatty acid content
WO1992018470A1 (en) Fatty acid monoglyceride polyglycol ether sulphosuccinates, their method of preparation and their use
EP1387666B1 (en) Two-phase cleansing agents having a high oil content
EP3250178B1 (en) Use of single phase tenside/oil/water preparations in cosmetic cleansing compositions
DE202019005940U1 (en) Glycolipid-containing cleaning preparation containing micelles

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020807

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

17Q First examination report despatched

Effective date: 20040329

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060308

Ref country code: IE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060308

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

Free format text: NOT ENGLISH

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

Free format text: LANGUAGE OF EP DOCUMENT: GERMAN

REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: TROESCH SCHEIDEGGER WERNER AG

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20060430

REF Corresponds to:

Ref document number: 50109158

Country of ref document: DE

Date of ref document: 20060504

Kind code of ref document: P

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060608

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060608

GBT Gb: translation of ep patent filed (gb section 77(6)(a)/1977)

Effective date: 20060605

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060808

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2258526

Country of ref document: ES

Kind code of ref document: T3

REG Reference to a national code

Ref country code: IE

Ref legal event code: FD4D

ET Fr: translation filed
PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20061211

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060609

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20060402

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 20080424

Year of fee payment: 8

Ref country code: ES

Payment date: 20080424

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: AT

Payment date: 20080423

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20080426

Year of fee payment: 8

Ref country code: BE

Payment date: 20080423

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20080625

Year of fee payment: 8

Ref country code: NL

Payment date: 20080422

Year of fee payment: 8

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060308

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20080418

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20080423

Year of fee payment: 8

BERE Be: lapsed

Owner name: *SASOL GERMANY G.M.B.H.

Effective date: 20090430

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20090402

NLV4 Nl: lapsed or anulled due to non-payment of the annual fee

Effective date: 20091101

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

Effective date: 20091231

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20090430

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20090402

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20091103

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20090430

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20091101

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20090402

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20091222

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20090430

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20090403

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20090403

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20090402

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20100922

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: TR

Payment date: 20080327

Year of fee payment: 8

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20090402